PD
RCUS icon

Point72 (DIFC)’s Arcus Biosciences RCUS Stock Holding History

Point72 (DIFC)’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,796
Closed -$104K – 1751
2025
Q2 		$104K Buy
+12,796
New +$109K ﹤0.01% 912
2025
Q1 		– Sell
-3,335
Closed -$49.7K – 2002
2024
Q4 		$49.7K Sell
3,335
-611
-15% -$9.98K ﹤0.01% 1126
2024
Q3 		$60.3K Sell
3,946
-1,515
-28% -$23.9K ﹤0.01% 1060
2024
Q2 		$83.2K Buy
+5,461
New +$88.1K ﹤0.01% 1003

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 (DIFC)'s RCUS Position: Q3 2025 in Review

Point72 (DIFC) sold out of Arcus Biosciences (RCUS) in Q3 2025, closing a stake of 12,796 shares — an estimated $104K sold.

Point72 (DIFC) first reported a position in RCUS in Q2 2024 and held it in 4 quarters. The position peaked at $104K in Q2 2025. 190 funds tracked by Wall St. Rank hold RCUS as of Q3 2025.

  • Point72 (DIFC) reported no remaining Arcus Biosciences position as of Q3 2025 after selling out during the quarter.
  • Point72 (DIFC) sold 12,796 Arcus Biosciences shares in Q3 2025, an estimated $104K.
  • Point72 (DIFC) first reported a position in Arcus Biosciences in Q2 2024 and held it in 4 quarters.
  • Point72 (DIFC)'s Arcus Biosciences position peaked at $104K in Q2 2025.
  • 190 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.